Molecular Mechanism of Ganglion Cell Death in Glaucoma
About the Research Project
Program
Award Type
Standard
Award Amount
$49,408
Active Dates
April 01, 1999 - March 31, 2001
Grant ID
G1999007
Summary
Susceptibility to glaucoma may be governed by multiple genes affecting different parts of the eye, for example, genes affecting intraocular pressure in the anterior part of the eye. However, damage to the eye in the form of neuronal cell death is the critical event leading to blindness, and Dr. Nickells’ long-range goal is to identify genes that contribute to the survival of ganglion cells under various conditions, including conditions that may mimic human glaucoma. To simplify the search for these genes, he proposes that strains of mice need to be developed that can be easily measured for changes in ganglion cell number. He is working to develop mice that express a marker gene that can be used to rapidly screen for the phenotype of ganglion cell variation. These mice can then be used for identifying the genes affecting ganglion cell survival.
Related Grants
National Glaucoma Research
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
National Glaucoma Research
Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Nazlee Zebardast, MD, MPH
Current Organization
Massachusetts Eye and Ear Infirmary
Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Nazlee Zebardast, MD, MPH
Current Organization
Massachusetts Eye and Ear Infirmary
National Glaucoma Research
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute